...
首页> 外文期刊>Journal of Medical Biochemistry >Association of fibrinogen and plasmin inhibitor, but not coagulation factor XIII gene polymorphisms with coronary artery disease
【24h】

Association of fibrinogen and plasmin inhibitor, but not coagulation factor XIII gene polymorphisms with coronary artery disease

机译:纤维蛋白原和纤溶酶抑制剂的缔合,但不是冠心病的凝血因子XIII基因多态性

获取原文

摘要

Background In the final phase of clot formation, fibrinogen constitutes frame, whereas factor XIII (FXIII) active form is responsible for the covalent cross-linking of fibrin fibres and plasmin inhibitor (PI), thus contributing to clot stability. It could be expected that any change of coagulation factors' structure affects the clot formation and modulates the atherothrombotic risk. The aim was to determine the frequency of four single nucleotide polymorphisms: ( i ) A & G in codon 312 of the fibrinogen α-chain gene (rs6050, Thr312AlaFGA), ( ii ) C & T at position 10034 of the 3 - untranslated region in the fibrinogen γ-chain gene (rs2066865, 10034C & T FGG), ( iii ) C & T in codon 564 of the FXIII-A subunit gene (rs5982, Pro564LeuFXIII-A), and ( iv ) C & T in codon 6 of the plasmin inhibitor gene (rs2070863, Arg6TrpPI) in Croatian patients and their association with coronary artery disease (CAD). Methods We performed the unrelated case-control association study on the consecutive sample of patients 18 years old, who had undergone coronary angiography for investigation of chest pain and suspected CAD. The cases were patients with confirmed CAD (N=201), and the controls were the subjects with no CAD (N=119). Samples were genotyped using PCR-RFLP analysis. Results Observed frequencies of the rare alleles of Thr312Ala FGA, 10034C & T FGG, Leu564Pro FXIII-A and Arg6Trp PI polymorphisms were 21%, 17%, 14%, 20%, respectively. Patients with 10034C & T FGG CC genotype had 3.5 times (95% CI 1.02-12.03) higher adjusted odds for CAD than patients with 10034C & T FGG TT genotype. Patients with Arg6Trp PI CC genotype had 3.86 times (95% CI 1.23-12.12) higher odds for CAD than patients with Arg6Trp PI TT genotype. It seems that those genotype-related higher odds are also male-gender related. No difference was observed regarding any other investigated polymorphism. Conclusions Our finding suggests that 10034C & T FGG and Arg6Trp PI are associated with CAD.
机译:背景技术在凝块形成的最终阶段,纤维蛋白原构成框架,而因子XIII(FXIII)活性形式是纤维蛋白纤维和纤溶酶抑制剂(PI)的共价交联(PI),从而有助于克罗茨稳定性。可以预期,任何凝血因子结构的变化都会影响凝块形成并调节动脉癌风险。目的是确定四种单核苷酸多态性的频率:(i)a& g在纤维蛋白原α-链基因的密码子312中(RS6050,THR312ALAFGA),(II)C>在纤维蛋白原γ-链基因中的3 - 未转换区域的位置10034(RS2066865,10034C& T FGG),(III)C> T在FXIII-A亚基基因的密码子564中(RS5982,PRO564LEUFFXIII-A)和(IV)C> C>克罗地亚患者血浆抑制剂基因(RS2070863,Arg6TrPPI)的密码子6及其与冠状动脉疾病(CAD)的关系。方法我们对18岁的患者的连续样本进行了无关的病例控制协会研究,该研究经历了冠状动脉造影,用于调查胸痛和疑似CAD。该病例是患有确认的CAD(n = 201)的患者,并且对照是没有CAD的受试者(n = 119)。使用PCR-RFLP分析进行样品进行基因分型。结果观察到Thr312Ala FGA,10034C&GT的罕见等位基因频率。 T FGG,Leu564Pro FXIII-A和Arg6TRP PI多态性分别为21%,17%,14%,20%。患者10034C& T FGG CC基因型具有3.5倍(95%CI 1.02-12.03)的CAD调整率高于10034C&GT的患者。 t fgg tt基因型。患有Arg6TRP PI CC基因型的患者具有3.86倍(95%CI 1.23-12.12)的CAD的可能性比Arg6TRP PI TT基因型的患者更高。似乎那些与基因型相关的较高的赔率也是男性性别相关的。关于任何其他研究多态性没有观察到差异。结论我们的发现表明10034C> t fgg和arg6trp pi与cad相关联。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号